C79.52
C79.52 — Secondary malignant neoplasm of bone marrow
Billable / specific codeICD-10-CM
C79.52 is a billable, specific ICD-10-CM code for secondary malignant neoplasm of bone marrow. It is valid for submission on a claim.
Risk adjustment
C79.52 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 18 Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid2.341 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C79.52 is named in 71 Medicare coverage policies — 71 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52453Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
- A52453Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
- A52453Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
- A52453Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
Related codes at this level
Codes that share C79.5. If C79.52 is not quite right, the correct code is usually one of these.
Questions about C79.52
- Is C79.52 a billable ICD-10-CM code?
- Yes. C79.52 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C79.52 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80).